{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Themis Medicare Technical Momentum Shifts Amid Market Challenges
Themis Medicare, a key player in the Pharmaceuticals & Biotechnology sector, has experienced notable shifts in its technical momentum, reflecting a complex interplay of bearish and bullish signals across multiple timeframes. Recent market data reveals a nuanced picture of price action and indicator behaviour, underscoring the challenges faced by the stock amid broader market dynamics.
Themis Medicare Technical Momentum Shifts Amid Market Volatility
Themis Medicare, a key player in the Pharmaceuticals & Biotechnology sector, has experienced notable shifts in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals across multiple timeframes. Recent market data reveals a nuanced picture of price action and indicator behaviour, underscoring the challenges faced by the stock amid broader market dynamics.
Why is Themis Medicare falling/rising?
On 21-Nov, Themis Medicare Ltd’s stock price fell by 3.43% to close at ₹108.50, continuing a downward trend that has seen the share price decline sharply over recent weeks and months, reflecting persistent financial challenges and weak market sentiment.
Is Themis Medicare technically bullish or bearish?
As of November 18, 2025, the technical trend is bearish with mixed signals from indicators, showing a prevailing bearish sentiment in the short to medium term.
Themis Medicare Technical Momentum Shifts Amid Bearish Trends
Themis Medicare, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a transition from mildly bearish to bearish trends. Recent technical indicators reveal a complex interplay of signals, with the stock price currently at ₹114.00, down 1.60% from the previous close of ₹115.85, amid a 52-week range of ₹98.00 to ₹313.65.
Themis Medicare Faces Financial Struggles Amidst Declining Sales and Profitability Metrics
Themis Medicare has reported a challenging financial quarter ending September 2025, marked by a significant decline in profit before tax and after tax, alongside decreased net sales. Despite achieving a high operating cash flow and a solid dividend payout ratio, key metrics indicate ongoing struggles and a lack of market confidence.
Why is Themis Medicare falling/rising?
As of 17-Nov, Themis Medicare Ltd's stock price is 116.15, reflecting a decline of 0.6% and a total drop of 5.45% over the last three days. The company is facing significant financial challenges, including a 20.08% decrease in net sales and a year-to-date decline of 55.86%, leading to a bearish market trend and lack of investor confidence.
Themis Medicare Faces Financial Challenges Amidst Strong Cash Flow and Dividend Payout
Themis Medicare has reported a challenging financial quarter ending September 2025, with significant declines in profit metrics and net sales. Despite achieving a record operating cash flow and a solid dividend payout, the company's stock has struggled, reflecting a stark contrast to broader market performance.
Themis Medicare Q2 FY26: Losses Deepen Amid Revenue Collapse
Themis Medicare Ltd. reported a consolidated net loss of ₹3.62 crores for Q2 FY26, marking a sharp deterioration from a profit of ₹14.29 crores in the year-ago quarter—a staggering 125.33% year-on-year decline. The small-cap pharmaceutical company, with a market capitalisation of ₹1,080.55 crores, saw its stock trading at ₹117.40 as of November 14, down 1.05% on the day and languishing 62.57% below its 52-week high of ₹313.65.
How has been the historical performance of Themis Medicare?
Themis Medicare has shown growth in net sales and total assets from March 2019 to March 2025, increasing from INR 183.75 crore to INR 405.51 crore in sales. However, profitability has declined, with profit after tax dropping from INR 61.54 crore in March 2022 to INR 23.90 crore in March 2025.
Why is Themis Medicare falling/rising?
As of 12-Nov, Themis Medicare Ltd's stock price is Rs 123.55, up 4.75% today, but it has declined 55.37% over the past year. The company's financial health is concerning, with significant operating profit declines and a lack of investor confidence reflected in zero domestic mutual fund investment.
Themis Medicare Faces Mixed Technical Trends Amidst Significant Yearly Decline
Themis Medicare, a small-cap pharmaceutical company, has faced significant challenges, reflected in its year-to-date return of -54.40%. Despite recent fluctuations in stock performance, the company has demonstrated resilience with a notable 250.72% return over the past five years, outperforming the Sensex's 93.02% return during the same period.
Why is Themis Medicare falling/rising?
As of 07-Nov, Themis Medicare Ltd's stock price is Rs 116.40, down 1.9%, with a total decline of 6.99% over the last three days and a year-to-date drop of 55.77%. The company's poor financial performance, including negative operating profits and a low Debt to EBITDA ratio, indicates a risky investment, contributing to its underperformance compared to the broader market.
Is Themis Medicare technically bullish or bearish?
As of November 6, 2025, Themis Medicare's technical trend is bearish, with dominant negative indicators across multiple time frames, despite some mixed signals in the weekly charts.
Themis Medicare Faces Technical Trend Shifts Amidst Market Volatility and Performance Challenges
Themis Medicare, a small-cap pharmaceutical company, has seen its stock price decline recently, with significant volatility reflected in its 52-week range. Despite facing challenges against the Sensex over the past year, the company has demonstrated resilience with substantial long-term returns, highlighting its fluctuating market position.
Why is Themis Medicare falling/rising?
As of 30-Oct, Themis Medicare Ltd's stock price is 124.65, down 0.52%, reflecting a downward trend with a total decline of 2.73% over the last two days and 3.07% over the past week. The company has reported negative operating profits for three consecutive quarters, contributing to its underperformance compared to the Sensex, which has seen a positive return of 5.15% over the past month.
Why is Themis Medicare falling/rising?
As of 10-Oct, Themis Medicare Ltd's stock price is Rs 130.95, down 5.42%, with a poor long-term growth outlook and negative results for the last three quarters. The stock has significantly underperformed the market, with a year-to-date decline of 50.24%, reflecting low investor confidence amid ongoing financial challenges.
Why is Themis Medicare falling/rising?
As of 09-Oct, Themis Medicare Ltd's stock price is Rs 138.45, up 11.74% today, reversing a five-day decline. Despite recent gains, the company faces significant challenges with declining profits and a long-term growth outlook, having dropped 48.82% over the past year.
Themis Medicare Soars to Day High with 12.19% Surge Amid Market Gains
Themis Medicare has seen a notable rise today, reaching an intraday high after a series of declines, suggesting a possible trend reversal. The stock has outperformed its sector and is currently above several key moving averages, amidst a generally positive market sentiment reflected by the Sensex's performance.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
